ERNESTO BERTARELLI
Sold biotech company Serono for $9 billion, won the America's Cup, and became Switzerland's richest person.
Ernesto Bertarelli took over his family's biotech company Serono at 32, grew it into the world's third-largest biotech firm, sold it to Merck for $9 billion, won the America's Cup in 2003 (the first European to do so in 152 years), and became Switzerland's richest person. He then invested the proceeds so well that his fortune has doubled since the sale. Most people who sell a company for $9 billion get bored. Bertarelli got richer.
Net Worth
$9 billion
Nationality
Swiss-Italian
Time Horizon
Generational
Risk Appetite
5 / 10
CAREER & BACKGROUND
Ernesto Bertarelli was born in 1965 in Rome. His father Fabio Bertarelli built Serono, originally Istituto Farmacologico Serono, from a small Italian pharmaceutical lab into a growing biotech company focused on fertility treatments, multiple sclerosis, and growth disorders.
Ernesto earned an MBA from Harvard Business School and joined Serono in 1985. When his father stepped back, Ernesto became CEO in 1996 at age 32.
Under his leadership, Serono grew dramatically. The company developed Rebif for multiple sclerosis and expanded its fertility drug franchise globally.
Revenue grew from hundreds of millions to over $3 billion. Serono became the world's third-largest biotech company.
In 2006, Bertarelli sold Serono to German pharmaceutical giant Merck KGaA for $9 billion. It was one of the largest biotech transactions in history.
With the proceeds, Bertarelli pivoted to investing. Through his family office Waypoint Capital, he invested in private equity, real estate, and public markets.
His fortune has roughly doubled since the sale, making him one of the most successful post-exit investors in European history.
He's also known for winning the America's Cup in 2003 with Team Alinghi, based in Switzerland. It was the first time a European team had won the cup in 152 years and the first time a landlocked country had won sailing's top prize.
COMPANIES & ROLES
Waypoint Capital is his family office and investment vehicle. It manages the Bertarelli fortune across private equity, real estate, public equities, and venture capital.
Fondation Bertarelli supports ocean science and conservation. Bertarelli is one of the largest private funders of marine research in the world.
Team Alinghi is his sailing team, which won the America's Cup in 2003 and defended it in 2007.
INVESTING STYLE & PHILOSOPHY
Diversified family office with a focus on private equity and real estate. After concentrating everything in one biotech company, Bertarelli now invests across many asset classes.
He's a patient, value-oriented investor. No day trading, no crypto speculation.
He buys quality assets and holds them long-term.
Ocean and conservation investments are a growing part of his portfolio, reflecting his personal passion for sailing and marine life.
THE PLAYBOOK
Risk Approach
Low to moderate post-Serono. He took enormous risk building Serono into a biotech giant.
Selling to Merck at $9 billion was a risk-off move. Since then, his investing has been conservative and diversified.
Money Habits
Bertarelli lives in Gstaad, Switzerland, and maintains residences in London and elsewhere. He's part of European high society and is regularly seen at major sailing, art, and social events.
Sailing is his passion. He has invested hundreds of millions in competitive sailing, including the America's Cup campaigns.
The sport is among the most expensive in the world.
His philanthropy focuses on marine conservation. The Fondation Bertarelli has funded the protection of over 2.7 million square kilometers of ocean, one of the largest private ocean conservation efforts in history.
BIGGEST WIN
Selling Serono for $9 billion. The timing was impeccable.
Biotech was consolidating, and independent companies were facing increasing pressure from big pharma. Merck paid a premium for Serono's fertility and MS franchises.
Winning the America's Cup in 2003 was the personal highlight. A landlocked Swiss team beating New Zealand, the defending champions, in New Zealand's home waters was one of the greatest upsets in sailing history.
BIGGEST MISTAKE
Serono had a legal controversy before the sale. In 2005, the company paid $704 million to settle a US Department of Justice investigation into illegal marketing of its growth hormone Serostim for AIDS-related wasting.
The settlement was one of the largest pharmaceutical fraud penalties at the time.
Bertarelli was CEO during the period of alleged illegal marketing, though he was not personally charged. The controversy clouded an otherwise remarkable business record.
FINANCIAL PHILOSOPHY
Know when to sell. Bertarelli sold Serono at or near the peak of its value.
The biotech industry was entering a consolidation phase, and independent biotechs were becoming harder to sustain. He got out at the right time.
Diversify after a concentrated win. Having made his fortune in a single company, Bertarelli deliberately spread the proceeds across many asset classes.
Wealth should serve a purpose. His ocean conservation work through the Fondation Bertarelli reflects a belief that wealth carries responsibility.
FAMILY & PERSONAL LIFE
Bertarelli is married to Kirsty Roper Bertarelli, a former Miss UK. They have three children.
The family splits time between Switzerland and their various properties.
Kirsty Bertarelli is also a songwriter who co-wrote the hit "Black Coffee" for the band All Saints. She is independently wealthy through her family's pharmaceutical business.
EDUCATION
Bertarelli earned a bachelor's degree from the University of Lausanne and an MBA from Harvard Business School.
BOOKS & RESOURCES
Bertarelli has not written a book
His story is covered in biotech industry histories and sailing literature
As an Amazon Associate, Netfigo earns from qualifying purchases. Book links above may be affiliate links.
QUOTES (5)
Knowing when to sell is harder than knowing when to buy. Most people get that backwards.
The ocean covers seventy percent of the planet and gets one percent of the attention. That is the biggest market inefficiency I know.
A landlocked country winning the America's Cup. That is proof that anything is possible with the right team and enough stubbornness.
Biotech is the only industry where one molecule can change everything. That is terrifying and exhilarating in equal measure.
NETFIGO SCORE
Proprietary 5-dimension investor rating
Risk Appetite
Contrarian Index
Track Record
Accessibility
Time Horizon
Related Profiles
Head-to-Head
Compare Ernesto Bertarelli vs another investor.